Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis

Condition:   Seborrheic Dermatitis Interventions:   Drug: Omiganan;   Drug: Ketoconazole;   Drug: Placebo Sponsor:   Cutanea Life Sciences, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials